Subscribe To
Roche (rhhby) gets fda approval for blood cancer drug columvi
Roche's (rhhby) blood cancer portfolio gets a boost with the approval of Columvi (glofitamab-gxbm) for ...
June 16, 2023, 1:51 pm
Roche (rhhby) announces positive results from pnh studies
Roche (rhhby) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in th...
June 12, 2023, 12:13 pm
Roche to present new data in blood cancers and solid tumours from its broad portfolio at asco 2023
Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: rhhby) will be presenting new data on six approved and...
May 26, 2023, 1:00 am
Jnana therapeutics announces milestone achieved under first collaboration with roche
Achievement of research milestone for immune program triggers milestone payment BOSTON, May 24, 2023 (GLOBE NEWSWIRE) — Jnana Therapeutics, a clinic...
May 24, 2023, 11:00 am
Roche's (rhhby) ms drug meets goals in the phase ii study
Roche's (rhhby) investigational oral fenebrutinib meets its primary and secondary endpoints in the phas...
May 17, 2023, 12:47 pm
Roche (rhhby) polivy combination for dlbcl gets full approval
Roche (rhhby) gets full approval for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan, cyc...
April 20, 2023, 3:13 pm
Roche (rhhby) announces data on tecentriq combo for hcc
Roche's (rhhby) new data from the late-stage IMbrave050 study reveals that the combination of Tecentriq...
April 17, 2023, 2:26 pm
Roche (rhhby) & lilly to co-develop alzheimer's detection device
Roche (rhhby) and Lilly announce a collaboration deal to support the development of the former's early ...
March 23, 2023, 11:27 am
Roche (rhhby) polivy combo backed by fda advisory committee
Roche (rhhby) gets majority votes from the FDA's Advisory Committee for Polivy combination for the trea...
March 10, 2023, 1:47 pm
Roche holding ag (rhhby) q4 2022 earnings call transcript
Roche Holding AG (OTCQX:rhhby) Q4 2022 Earnings Conference Call February 2, 2023 8:00 AM ET Company Par...
February 2, 2023, 4:02 pm
Roche (rhhby) gets eu approval for xofluza in new patient base
The European Commission approves Roche's (rhhby) Xofluza for treating uncomplicated influenza and post-...
January 12, 2023, 2:18 pm
Roche's (rhhby) cancer drug glofitamab gets fda priority review
The FDA accepts and grants priority review to Roche's (rhhby) biologics license application for glofita...
January 6, 2023, 12:02 pm
Roche (rhhby) actemra gets fda nod for adults with covid-19
Roche (rhhby) obtains FDA approval for Actemra (tocilizumab) intravenous (IV) for the treatment of COVI...
December 22, 2022, 10:33 am
Genentech to present scientific progress across alzheimer's disease pharmaceutical and diagnostic portfolio at 2022 aaic annual meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: rhh...
July 28, 2022, 1:00 am
Roche to present scientific progress across alzheimer's disease pharmaceutical and diagnostic portfolio at 2022 aaic annual meeting
Basel, 28 July 2022 - Roche (SIX: RO, ROG; OTCQX: rhhby) today announced that data from 41 abstracts ac...
July 28, 2022, 1:00 am
Roche holding ag (rhhby) ceo severin schwan on q2 2022 results - earnings call transcript
Roche Holding AG (OTCQX:rhhby) Q2 2022 Results Conference Call July 21, 2022 8:00 AM ET Company Partici...
July 21, 2022, 2:52 pm
Bayry vs. rhhby: which stock is the better value option?
BAYRY vs. rhhby: Which Stock Is the Better Value Option?...
July 12, 2022, 1:06 pm
Roche's (rhhby) lunsumio application gets priority review
Roche's (rhhby) BLA application seeking approval for the use of Lunsumio for relapsed or refractory fol...
July 6, 2022, 2:45 pm
Roche (rhhby) alzheimer's disease drug data disappoints
Roche's (rhhby) study evaluating crenezumab in autosomal dominant Alzheimer's disease did not slow or p...
June 16, 2022, 1:52 pm
Roche-ac immune's crenezumab fails to show benefit in sub-set of alzheimer's patients
Roche Holdings AG (OTC: rhhby) said its Alzheimer's medicine crenezumab did not slow or prevent cogni...
June 16, 2022, 8:36 am